Ionis Pharmaceuticals, Inc.IONSNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+10.0%
5Y CAGR+8.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+10.0%/yr
vs +10.5%/yr prior
5Y CAGR
+8.0%/yr
Consistent
Acceleration
-0.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.31B | +12.0% |
| 2024 | $1.17B | +3.2% |
| 2023 | $1.13B | +15.1% |
| 2022 | $983.44M | +18.5% |
| 2021 | $829.80M | -6.7% |
| 2020 | $889.40M | +18.2% |
| 2019 | $752.33M | +14.1% |
| 2018 | $659.23M | +36.4% |
| 2017 | $483.13M | +23.0% |
| 2016 | $392.94M | - |